8-K ·Filed Aug 14, 2026

FOCL

EDAP TMS SA
BEARISH
Impact 6/10
Horizonimmediate Processed1mo ago SEC0001104659-26-096209
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight ▼ Bearish

The dilutive secondary offering will increase share count by ~22.5%, likely putting near-term downward pressure on the stock. Monitor the stock for typical negative price reaction around the offering close. The lock-up agreements may limit insider selling for 90 days, but the underwriter option overhang could weigh on sentiment.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
FOCL ▼ -13.66% at T+20d
SHORT call ✓ call won +13.66% · α vs SPY +11.66% · entry $4.76 → $4.11
Next anchor: T+60d in 5w
Latest observation: T+31 +11.87% FF3 residual α
Entry anchored
Aug 14, 2026
via day open
T+1d
-8.40%
call +8.40% · α +7.93%
$4.36
settled 7w ago
T+5d
-13.24%
call +13.24% · α +11.87%
$4.13
settled 6w ago
T+20d
-13.66%
call +13.66% · α +11.66%
$4.11
settled 19d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

EDAP TMS S.A. (FOCL) entered into an underwriting agreement for a public offering of 8,425,000 ADSs at $4.75 per ADS, with an underwriter option for up to an additional 1,263,750 ADSs. Net proceeds are expected to be approximately $37.1 million, which will be used for operating costs, capital expenditures, and general corporate purposes. The offering represents roughly 22.5% dilution relative to the current market cap and is expected to close on August 14, 2026.

Key Facts

  • Underwritten public offering of 8,425,000 ADSs at $4.75 per ADS
  • Underwriters have a 30-day option to purchase up to an additional 1,263,750 ADSs
  • Net proceeds expected to be approximately $37.1 million
  • Offering expected to close on August 14, 2026
  • Underwriters include TD Securities, Mizuho Securities, H.C. Wainwright, and Lucid Capital Markets
  • Executive officers and directors entered into 90-day lock-up agreements
  • Shares issued via capital increase without preemptive subscription rights

Financial Impact

Dilution of approximately 22.5% based on current market cap of $178M; gross proceeds of ~$40.0M before expenses, net proceeds ~$37.1M

dilutionshare count

Risk Factors

  • Significant dilution to existing shareholders
  • Potential downward price pressure from the offering
  • Proceeds used for general corporate purposes may not be value-accretive

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
73% bullish (11 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-096209
Document: tm2622525d4_8k.htm0001104659-26-096209
Document: tm2622525d4_ex5-1.htm0001104659-26-096209
Document: 0001104659-26-096209-index-headers.html0001104659-26-096209
Document: 0001104659-26-096209-index.html0001104659-26-096209
Document: 0001104659-26-096209.txt0001104659-26-096209
6 reports for FOCL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FOCL — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
8-K
BEARISH ★ 6/10
$4.36 $4.28▲ +1.83%▼ −0.12%$4.20 (+3.67%)
Aug 14, 2026
7w ago
8-K
BEARISH ★ 6/10
$4.76 $4.11▲ +13.66%▲ +11.66%$4.20 (+11.76%)
Aug 13, 2026
7w ago
8-K
MIXED ★ 6/10
$4.76 $4.11▼ −13.66%▼ −11.66%$4.20 (−11.76%)
Aug 12, 2026
7w ago
Press Release
MIXED ★ 6/10
$4.75 $4.16▼ −12.42%▼ −10.52%$4.20 (−11.58%)
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$4.75 $4.16▼ −12.42%▼ −10.52%$4.20 (−11.58%)
Jul 30, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$6.12 $4.31▼ −29.58%▼ −32.56%$4.20 (−31.37%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (35h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access